{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:22:51Z","timestamp":1792419771364,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cytogfr.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:28:50Z","timestamp":1768350530000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["GDF15 in the tumor microenvironment: A central mediator of cancer immunometabolism and therapeutic resistance"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-0809","authenticated-orcid":false,"given":"Lingeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda L.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10549-017-4281-x","article-title":"Elevated T cell activation score is associated with improved survival of breast cancer","volume":"164","author":"Lu","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2024.11.002","article-title":"Genetic immune escape in cancer: timing and implications for treatment","volume":"11","author":"Martinez-Jimenez","year":"2025","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41588-023-01367-1","article-title":"Genetic immune escape landscape in primary and metastatic cancer","volume":"55","author":"Martinez-Jimenez","year":"2023","journal-title":"Nat. Genet"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-024-03398-5","article-title":"Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data","volume":"31","author":"Yoo","year":"2025","journal-title":"Nat. Med."},{"issue":"8048","key":"10.1016\/j.cytogfr.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41586-024-08305-z","article-title":"Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours","volume":"637","author":"Melero","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.trecan.2025.06.007","article-title":"GDF15: from biomarker to target in cancer cachexia","volume":"11","author":"Hullwegen","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","article-title":"The GDF15-GFRAL pathway in health and metabolic disease: friend or foe?","volume":"83","author":"Breit","year":"2021","journal-title":"Annu Rev. Physiol."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","article-title":"Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets","volume":"31","author":"Rochette","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76272","article-title":"Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans","volume":"11","author":"Lemmela","year":"2022","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QCO.0b013e328344f50f","article-title":"Inflammation and cardiac outcome","volume":"24","author":"Hohensinner","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.3390\/ijms25137313","article-title":"Macrophages as a source and target of GDF-15","volume":"25","author":"Silva-Bermudez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib15","article-title":"Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases","volume":"9","author":"di Candia","year":"2021","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40618-023-02232-y","article-title":"Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans","volume":"47","author":"Pena-Leon","year":"2024","journal-title":"J. Endocrinol. Invest"},{"issue":"16","key":"10.1016\/j.cytogfr.2026.01.004_bib17","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14535","article-title":"Effect of menopausal hormone therapy on proteins associated with senescence and inflammation","volume":"8","author":"Faubion","year":"2020","journal-title":"Physiol. Rep."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep4.1363","article-title":"Selective liver estrogen receptor alpha modulation prevents steatosis, diabetes, and obesity through the anorectic growth differentiation factor 15 hepatokine in mice","volume":"3","author":"Guillaume","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41389-022-00397-4","article-title":"Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression","volume":"11","author":"Chen","year":"2022","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10522-024-10164-0","article-title":"GDF15\/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process","volume":"26","author":"Salminen","year":"2024","journal-title":"Biogerontology"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101569","article-title":"GDF15, an emerging key player in human aging","volume":"75","author":"Conte","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.arr.2014.05.004","article-title":"Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process","volume":"16","author":"Salminen","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.omtn.2018.05.016","article-title":"EZH2-mediated epigenetic suppression of GDF15 predicts a poor prognosis and regulates cell proliferation in non-small-cell lung cancer","volume":"12","author":"Lu","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113503","article-title":"The upregualtion of GDF15 is controlled epigenetically by oncogenic TCG19 signaling in human hepatocellular carcinoma","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9398401","article-title":"Growth differentiation factor 15 may predict mortality of peripheral and coronary artery diseases and correlate with their risk factors","volume":"2017","author":"Hsu","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.004_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183187","article-title":"A GDF15 3\u2032 UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p","volume":"12","author":"Teng","year":"2017","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.cytogfr.2026.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.70124","article-title":"Health implications of racial differences in serum growth differentiation factor levels among men with obesity","volume":"12","author":"Bathina","year":"2024","journal-title":"Physiol. Rep."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/biomedicines13071589","article-title":"Investigating the role of GDF-15 in diabetes and obesity: a comprehensive analysis of a cohort from the KDEP study","volume":"13","author":"Abubaker","year":"2025","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat. Med."},{"issue":"7675","key":"10.1016\/j.cytogfr.2026.01.004_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.004_bib31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055174","article-title":"TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41574-019-0167-9","article-title":"GDF15 signals nutritional stress","volume":"15","author":"Starling","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tem.2018.05.002","article-title":"Uniting GDF15 and GFRAL: therapeutic opportunities in obesity and beyond","volume":"29","author":"Mullican","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111947","article-title":"GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia","volume":"42","author":"Kim-Muller","year":"2023","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.cytogfr.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer Cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011036","article-title":"Ectopic expression of GDF15 in cancer-associated fibroblasts enhances melanoma immunosuppression via the GFRAL\/RET cascade","volume":"13","author":"Zhao","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10585-020-10041-3","article-title":"Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients","volume":"37","author":"Spanopoulou","year":"2020","journal-title":"Clin. Exp. Metastas.."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3233\/CBM-170792","article-title":"Growth\/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer","volume":"21","author":"Vocka","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib41","article-title":"GDF-15 as a biomarker for diagnosis and prognosis of lung cancer: a meta-analysis","volume":"15","author":"Pan","year":"2025","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.6205","article-title":"GDF15 promotes EMT and metastasis in colorectal cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.004_bib43","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/s44321-024-00105-2","article-title":"The MondoA-dependent TXNIP\/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas","volume":"16","author":"Deng","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12672-025-02121-1","article-title":"Mapping growth differentiation factor-15 (GDF15)-mediated signaling pathways in cancer: insights into its role across different cancer types","volume":"16","author":"Rai","year":"2025","journal-title":"Discov. Oncol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.004_bib45","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1158\/1535-7163.MCT-09-0158","article-title":"Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells","volume":"8","author":"Proutski","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.004_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112394","article-title":"HIF1alpha promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer","volume":"398","author":"Zheng","year":"2021","journal-title":"Exp. Cell Res"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgn031","article-title":"Macrophage inhibitory cytokine-1 activates AKT and ERK-1\/2 via the transactivation of ErbB2 in human breast and gastric cancer cells","volume":"29","author":"Kim","year":"2008","journal-title":"Carcinogenesis"},{"issue":"15","key":"10.1016\/j.cytogfr.2026.01.004_bib48","doi-asserted-by":"crossref","first-page":"24869","DOI":"10.18632\/oncotarget.15276","article-title":"An autocrine\/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells","volume":"8","author":"Sasahara","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.004_bib49","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bcp.2011.07.082","article-title":"Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells","volume":"82","author":"Joshi","year":"2011","journal-title":"Biochem Pharm."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/eji.200738111","article-title":"The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function","volume":"38","author":"Shevach","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.004_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08830185.2024.2411998","article-title":"Transforming growth factor-beta in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting","volume":"44","author":"Hourani","year":"2025","journal-title":"Int Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41417-025-00886-9","article-title":"MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy","volume":"32","author":"Ibrahim","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.01.004_bib54","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1158\/1078-0432.CCR-13-2797","article-title":"Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma","volume":"20","author":"Atefi","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216318","article-title":"The opportunities and challenges in immunotherapy: insights from the regulation of PD-L1 in cancer cells","volume":"569","author":"Lin","year":"2023","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib56","doi-asserted-by":"crossref","first-page":"e003402","DOI":"10.1136\/jitc-2021-003402","article-title":"PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment","volume":"10","author":"Collins","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.004_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159473","article-title":"Cross-talk between HIF and PD-1\/PD-L1 pathways in carcinogenesis and therapy","volume":"132","author":"Shurin","year":"2022","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.004_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-14-3362","article-title":"Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111457","article-title":"GDF15 enhances anoikis resistance and metastasis of gastric cancer through protective autophagy","volume":"124","author":"Gao","year":"2024","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s42003-023-04965-1","article-title":"Stress-responsive Gdf15 counteracts renointestinal toxicity via autophagic and microbiota reprogramming","volume":"6","author":"Ray","year":"2023","journal-title":"Commun. Biol."},{"issue":"43","key":"10.1016\/j.cytogfr.2026.01.004_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn1702","article-title":"Beyond autophagy: LC3-associated phagocytosis and endocytosis","volume":"8","author":"Pena-Martinez","year":"2022","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/1873-3468.14280","article-title":"Novel and conventional inhibitors of canonical autophagy differently affect LC3-associated phagocytosis","volume":"596","author":"Stempels","year":"2022","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib63","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbrc.2011.01.076","article-title":"Phagocytosis is inhibited by autophagic induction in murine macrophages","volume":"405","author":"Lima","year":"2011","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289753","article-title":"The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173004","article-title":"Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function","volume":"12","author":"Ottman","year":"2017","journal-title":"PLoS One"},{"issue":"6446","key":"10.1016\/j.cytogfr.2026.01.004_bib67","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1126\/science.aaw7479","article-title":"Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis","volume":"364","author":"Ansaldo","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115084","article-title":"16S rRNA target sequencing of human tumors validates findings of Lachnoclostridium abundance in human melanomas that are heavily CD8+ T-cell infiltrated","volume":"213","author":"Lu","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2021.03.053","article-title":"Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma","volume":"151","author":"Zhu","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"6371","key":"10.1016\/j.cytogfr.2026.01.004_bib70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib71","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","article-title":"Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab","volume":"28","author":"Chaput","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib72","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419846379","article-title":"Cancer immune checkpoint inhibitor therapy and the gut microbiota","volume":"18","author":"Frankel","year":"2019","journal-title":"Integr. Cancer Ther."},{"issue":"6529","key":"10.1016\/j.cytogfr.2026.01.004_bib73","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.cytogfr.2026.01.004_bib74","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004779","article-title":"Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma","volume":"10","author":"Lee","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"7791","key":"10.1016\/j.cytogfr.2026.01.004_bib76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib77","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.004_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002787","article-title":"GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib79","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12951-025-03182-8","article-title":"Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles","volume":"23","author":"Zou","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib81","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2147\/CMAR.S192095","article-title":"Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma","volume":"11","author":"Peng","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216184","article-title":"YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer","volume":"563","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.004_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078618","article-title":"Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112522","article-title":"Growth differentiation factor-15 promotes immune escape of ovarian cancer via targeting CD44 in dendritic cells","volume":"402","author":"Gao","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.004_bib85","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1172\/JCI91561","article-title":"NF-kappaB regulates GDF-15 to suppress macrophage surveillance during early tumor development","volume":"127","author":"Ratnam","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"7693","key":"10.1016\/j.cytogfr.2026.01.004_bib86","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"issue":"6487","key":"10.1016\/j.cytogfr.2026.01.004_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib88","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib89","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12931-024-02824-z","article-title":"GDF15 ameliorates sepsis-induced lung injury via AMPK-mediated inhibition of glycolysis in alveolar macrophage","volume":"25","author":"Lu","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.cytogfr.2026.01.004_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155772","article-title":"GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-beta1\/SMAD3 pathway","volume":"152","author":"Jurado-Aguilar","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106578","article-title":"A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects","volume":"187","author":"Aguilar-Recarte","year":"2023","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40170-025-00373-7","article-title":"GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGFbeta signaling pathway","volume":"13","author":"Xue","year":"2025","journal-title":"Cancer Metab."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.004_bib93","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib94","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 Activation-Induced Fatty Acid Oxidation in CD8(+) T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41420-024-01807-9","article-title":"Fatty acid metabolism of immune cells: a new target of tumour immunotherapy","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib97","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-021-00781-x","article-title":"Diet, lipids, and antitumor immunity","volume":"19","author":"Prendeville","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib98","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.apsb.2022.10.027","article-title":"The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"24","key":"10.1016\/j.cytogfr.2026.01.004_bib100","doi-asserted-by":"crossref","first-page":"13608","DOI":"10.3390\/ijms222413608","article-title":"GDF15 Supports the Inflammatory Response of PdL Fibroblasts Stimulated by P. gingivalis LPS and Concurrent Compression","volume":"22","author":"Stemmler","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.004_bib101","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ccell.2025.07.005","article-title":"Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer","volume":"43","author":"Ghisoni","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.004_bib102","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib103","article-title":"Plasma GDF15 affects long-term dementia risk and alters neuro-immune signaling","author":"Blew","year":"2025","journal-title":"medRxiv"},{"issue":"8011","key":"10.1016\/j.cytogfr.2026.01.004_bib104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE(2) limits effector expansion of tumour-infiltrating stem-like CD8(+) T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"issue":"8046","key":"10.1016\/j.cytogfr.2026.01.004_bib105","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","article-title":"Cancer cells impair monocyte-mediated T cell stimulation to evade immunity","volume":"637","author":"Elewaut","year":"2025","journal-title":"Nature"},{"issue":"8011","key":"10.1016\/j.cytogfr.2026.01.004_bib106","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.004_bib107","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imm.13887","article-title":"FOXP3 transcriptionally activates fatty acid scavenger receptor CD36 in tumour-induced treg cells","volume":"174","author":"Dhar","year":"2025","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib108","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib109","article-title":"Inflammaging and fatty acid oxidation in monocytes and macrophages","volume":"6","author":"Kruglov","year":"2024","journal-title":"Immunometabolism (Cobham)"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2017.12.011","article-title":"Fatty acid oxidation contributes to IL-1beta secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration","volume":"94","author":"Zhang","year":"2018","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101341","article-title":"Macrophage polarization state affects lipid composition and the channeling of exogenous fatty acids into endogenous lipid pools","volume":"297","author":"Morgan","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib112","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/s41467-025-58452-8","article-title":"Investigative needle core biopsies support multimodal deep-data generation in glioblastoma","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib113","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/s41467-022-32430-w","article-title":"Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma","volume":"13","author":"Coy","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib114","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","article-title":"Linoleic acid potentiates CD8(+) T cell metabolic fitness and antitumor immunity","volume":"35","author":"Nava Lauson","year":"2023","journal-title":"Cell Metab."},{"issue":"15","key":"10.1016\/j.cytogfr.2026.01.004_bib115","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","article-title":"GDF-15 contributes to proliferation and immune escape of malignant gliomas","volume":"16","author":"Roth","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.004_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309394","article-title":"Neutralizing antibody against GDF15 for treatment of cancer-associated cachexia","volume":"19","author":"Xiong","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib117","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2416453","article-title":"GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models","volume":"16","author":"Huang","year":"2024","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib118","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-025-01664-8","article-title":"IL-15: from discovery to FDA approval","volume":"18","author":"Li","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.004_bib119","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-beta Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib120","unstructured":"Johnson M. 2019 Identification of first in class small molecule GFRAL blockers for the prevention and reversal of Cancer Anorexia-Cachexia. NIH <\u3008https:\/\/grantome.com\/grant\/NIH\/R43-CA239961-01A1\u3009>."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.004_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400961","article-title":"GDF15 Analogues Acting as GFRAL Ligands","volume":"20","author":"Di Santo","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib122","unstructured":"SantaCruzBiotechnology. 2025 GDF-15 inhibitors. < \u3008https:\/\/www.scbt.com\/browse\/gdf-15-inhibitors?srsltid=AfmBOopsQ8ZuALRIW7F_Ju_7mfs_ZZAXcJNl_2FKed853OYWLYUM8850\u3009>."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.004_bib123","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acschembio.7b00657","article-title":"CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine","volume":"13","author":"Kampmann","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.004_bib124","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/0115665240327723241018073535","article-title":"The Hormetic Potential of GDF15 in Skeletal Muscle Health and Regeneration: A Comprehensive Systematic Review","volume":"25","author":"Tarchi","year":"2025","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156727","article-title":"Growth differentiation factor 15: Emerging role in liver diseases","volume":"182","author":"Li","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1514518","article-title":"A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration","volume":"15","author":"Isik","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib127","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12885-024-12727-3","article-title":"The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer","volume":"24","author":"Akdogan","year":"2024","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib128","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality","volume":"9","author":"Wiklund","year":"2010","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.004_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14136","article-title":"Plasma proteomic signature of human longevity","volume":"23","author":"Liu","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.cytogfr.2026.01.004_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109574","article-title":"Circulating levels of growth differentiation factor 15 and sex hormones in male patients with HBV-associated hepatocellular carcinoma","volume":"121","author":"Chen","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.004_bib131","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152616","article-title":"Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing","volume":"7","author":"Guo","year":"2022","journal-title":"JCI Insight"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:36:37Z","timestamp":1773459397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":131,"alternative-id":["S1359610126000043"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GDF15 in the tumor microenvironment: A central mediator of cancer immunometabolism and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}